Does anyone in the EU have mutation N1303K and is approved for Kaftrio or Alyftrek?
I'm asking people without the F508 mutation as that one is approved for everything.
I'm trying to find out which EU countries have one or both these medicines approved officially for the mutation N1303K. I spent last night looking for the answers online but they're not so clear.
Thanks for letting me know!